Vidipha Central Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -6.84% vs 4.38% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -15.69% vs -19.46% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "195,923.70",
          "val2": "210,306.10",
          "chgp": "-6.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20,938.90",
          "val2": "27,929.40",
          "chgp": "-25.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2,257.40",
          "val2": "2,489.70",
          "chgp": "-9.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11,917.60",
          "val2": "14,135.00",
          "chgp": "-15.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "69.00%",
          "val2": "97.00%",
          "chgp": "-2.80%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.47% vs -8.32% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -11.16% vs -10.47% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "985,636.70",
          "val2": "934,486.80",
          "chgp": "5.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "112,748.20",
          "val2": "112,234.30",
          "chgp": "0.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10,446.80",
          "val2": "14,848.80",
          "chgp": "-29.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "63,807.30",
          "val2": "71,823.20",
          "chgp": "-11.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "84.00%",
          "val2": "87.60%",
          "chgp": "-0.36%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

195,923.70

210,306.10

-6.84%

Operating Profit (PBDIT) excl Other Income

20,938.90

27,929.40

-25.03%

Interest

2,257.40

2,489.70

-9.33%

Exceptional Items

0.00

0.00

Consolidate Net Profit

11,917.60

14,135.00

-15.69%

Operating Profit Margin (Excl OI)

69.00%

97.00%

-2.80%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -6.84% vs 4.38% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -15.69% vs -19.46% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

985,636.70

934,486.80

5.47%

Operating Profit (PBDIT) excl Other Income

112,748.20

112,234.30

0.46%

Interest

10,446.80

14,848.80

-29.65%

Exceptional Items

0.00

0.00

Consolidate Net Profit

63,807.30

71,823.20

-11.16%

Operating Profit Margin (Excl OI)

84.00%

87.60%

-0.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 5.47% vs -8.32% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -11.16% vs -10.47% in Dec 2024

All Annual Results